Novavax (NASDAQ: NVAX) Cuts 2024 Revenue Forecast Amid Weaker COVID Vaccine Sales; Stock Falls
On Tuesday, Novavax (NASDAQ: NVAX) cut its annual revenue forecast, citing lower-than-expected sales of its COVID-19 vaccine, ahead of handing […]
Novavax
Novavax and UK Officially Terminate COVID-19 Vaccine Supply Contract
On Tuesday, Novavax (NASDAQ: NVAX) said it has entered into a termination and settlement agreement with the UK Health Security
Novavax and UK Officially Terminate COVID-19 Vaccine Supply Contract Read More »
Novavax (NASDAQ: NVAX) Stock Tumbles After FDA Pauses COVID-Flu Vaccine Trial
The U.S. Food and Drug Administration has put on hold a trial of Novavax’s (NASDAQ: NVAX) COVID-influenza and its standalone
Novavax (NASDAQ: NVAX) Stock Tumbles After FDA Pauses COVID-Flu Vaccine Trial Read More »
Novavax (NASDAQ: NVAX) Secures EU Approval for New COVID-19 Vaccine Targeting JN.1 Strain
The European Commission authorized Novavax’s (NASDAQ: NVAX) updated COVID-19 vaccine targeting the JN.1 strain of coronavirus in the region, the
FDA Authorizes Novavax (NASDAQ: NVAX) Updated COVID Vaccine Targeting JN.1 Strain
On Friday, the U.S. Food and Drug Administration granted emergency use authorization for an updated version of Novavax’s (NASDAQ: NVAX)
FDA Authorizes Novavax (NASDAQ: NVAX) Updated COVID Vaccine Targeting JN.1 Strain Read More »
Novavax (NASDAQ: NVAX) Slashes 2024 Revenue Guidance Again, To Cut European Presence
On Thursday, Novavax (NASDAQ: NVAX) trimmed its annual revenue forecast again and said it would pare back its presence in
Novavax (NASDAQ: NVAX) Slashes 2024 Revenue Guidance Again, To Cut European Presence Read More »
Novavax (NASDAQ: NVAX) Stock Skyrockets as TD Cowen Analyst Lifts Price Target
Novavax (NASDAQ: NVAX) stock climbed almost 50% in intraday trading Monday after TD Cowen analyst raised its price target. Brendan
Novavax (NASDAQ: NVAX) Stock Skyrockets as TD Cowen Analyst Lifts Price Target Read More »
Novavax (NASDAQ: NVAX) Stock Doubles Amid COVID-19 License Deal and ‘Going Concern’ Withdrawal
Novavax (NASDAQ: NVAX) stock soared almost 100% in intraday trading after signing a COVID-19 license deal with Sanofi and withdrawing
Novavax, Inc. (NASDAQ: NVAX) Shares Surge on Two Key Announcements
Shares of Novavax, Inc. (NASDAQ: NVAX) surged 28.15% on Monday following two major announcements: the revised agreement with the Government
Novavax, Inc. (NASDAQ: NVAX) Shares Surge on Two Key Announcements Read More »
